secwatch.observer — SEC 8-K summary
======================================

Issuer:     BELLICUM PHARMACEUTICALS, INC (—)
CIK:        0001358403
Form:       8-K
Filed at:   2024-02-21T23:59:59+00:00
Accession:  0001539497-24-000541
Event type: m_and_a
Sentiment:  negative
Materiality: 0.85
Item codes: 2.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bellicum Pharmaceuticals completes $8.1M asset sale to MD Anderson; stockholder approval of dissolution
--------------------------------------------------------------------------------

- Sale of CaspaCIDe, iMC, GoCAR-T, and Rimiducid assets to MD Anderson for $8.1M cash.
- Stockholders approved both the asset purchase agreement and dissolution plan at reconvened special meeting on Feb 20, 2024.
- Super Voting Stock holder cast 11,901,026 votes; total 15,626,551 votes present for quorum.
- Asset Sale Proposal passed with 14,372,239 for, 1,243,426 against; Dissolution Proposal passed with 14,317,520 for.
- Company now plans to liquidate and dissolve under Delaware law, subject to satisfaction of liabilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1358403/000153949724000541/0001539497-24-000541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1358403/000153949724000541/n3936_x4-8k.htm
  HTML page:      https://secwatch.observer/filing/0001539497-24-000541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer